Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

11.33
Delayed Data
As of 3:59pm ET
 +0.72 / +6.79%
Today’s Change
6.25
Today|||52-Week Range
13.56
+17.41%
Year-to-Date
Is Teva Pharmaceuticals a Safe Stock to Buy Now?
Feb 21 / MotleyFool.com - Paid Partner Content
TEVA Stock Declines Despite Q4 Earnings and Sales Beat
Feb 11 / Zacks.com - Paid Partner Content
2 Stocks I'd Avoid at All Costs
Feb 20 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close10.61
Today’s open10.64
Day’s range10.55 - 11.47
Volume15,957,137
Average volume (3 months)9,189,853
Market cap$12.2B
Data as of 3:59pm ET, 02/24/2021

Growth & Valuation

Earnings growth (last year)-299.46%
Earnings growth (this year)+1.83%
Earnings growth (next 5 years)+4.03%
Revenue growth (last year)-0.90%
P/E ratioNM
Price/Sales0.63
Price/Book1.22

Competitors

 Today’s
change
Today’s
% change
BBIOBridgeBio Pharma Inc+1.58+2.40%
IMMBImmunotech Laborator...0.000.00%
----
BGNEBeigene Ltd+2.10+0.63%
Data as of 3:59pm ET, 02/24/2021

Financials

Next reporting dateMay 13, 2021
EPS forecast (this quarter)$0.59
Annual revenue (last year)$16.8B
Annual profit (last year)-$4.0B
Net profit margin-23.95%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
No executives to display
Corporate headquarters
Petach Tikva, Hamerkaz

Forecasts